LIPO | tickerfilter.com

Fundamental analysis

28%

Profitability 0%

Dept financing 32%

Liquidity 50%

Performance 50%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

0.23%

1 Month

-43.56%

3 Months

-18.89%

6 Months

411.68%

1 Year

184.42%

2 Year

15.87%

Key data

Stock price

$2.19

P/E Ratio

0.00

DAY RANGE

$2.16 - $2.30

EPS

-$1.57

52 WEEK RANGE

$0.28 - $7.31

52 WEEK CHANGE

$180.84

MARKET CAP

3.778 M

YIELD

N/A

SHARES OUTSTANDING

8.005 M

DIVIDEND

$0.00

EX-DIVIDEND DATE

11-08-2024

NEXT EARNINGS DATE

N/A

BETA

1.05

PUBLIC FLOAT

AVERAGE 10 VOLUME

$61,109

AVERAGE 30 VOLUME

$176,136

Company detail

CEO: Jon Kaufman
Region: US
Website: lipella.com
Employees: 4
IPO year: 2022

Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

We are a clinical-stage biotechnology company focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. Our principal executive offices are located at 7800 Susquehanna Street, Suite 505, Pittsburgh, PA.

LIPO - Lipella Pharmaceuticals Inc